The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA
| Image |  |
|---|---|
| Description | scientific article published on 24 August 2020 |
| Author/s |
author: Frank Essmann Klaus Schulze-Osthoff |
| Publication date | August 24, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |